Company Info
Kane Biotech Inc. is a Canadian biotechnology company that was established in 2001. It is publicly traded on the TSX Venture Exchange under the ticker symbol KNE. Headquartered in Winnipeg, Manitoba, Kane Biotech focuses on developing and commercializing technologies and products that target biofilms, which are complex communities of microorganisms that can form on surfaces and contribute to various medical and industrial challenges. The company leverages a strong foundation in biofilm research to create innovative solutions for healthcare, animal health, and industrial applications. Its products and technologies are designed to manage and prevent biofilm formation, offering practical solutions for improving hygiene, health, and performance in diverse settings. By combining scientific expertise with a commitment to innovation, Kane Biotech has positioned itself as a leader in the growing field of biofilm research and management.